Finch Therapeutics Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	25.12	71.04	133.48	99.71	42.19
Cash & Cash Equivalents	25.12	71.04	133.48	99.71	42.19
Cash Growth	-64.63%	-46.78%	33.87%	136.36%	-
Receivables	0	0.14	0.49	1.1	4.75
Inventory	0	-3.51	-9.07	0	0
Other Current Assets	0.72	3.37	8.58	5.36	1.69
Total Current Assets	25.85	71.04	133.48	106.16	48.63
Property, Plant & Equipment	27.18	48.69	24.69	7	3.78
Long-Term Investments	2.35	2.57	2.27	0.2	0.21
Goodwill	0	0	18.06	18.06	18.06
Intangible Assets	0	32.9	32.9	32.9	32.9
Other Long-Term Assets	17.97	7.75	13.98	1.01	0
Total Long-Term Assets	45.15	91.9	91.89	59.17	54.94
Total Assets	71	162.94	225.37	165.34	103.57
Accounts Payable	0.14	1.1	3.74	2.62	0.66
Deferred Revenue	-0	0	0	3.37	2.38
Current Debt	1.72	3.43	1.13	0	0
Other Current Liabilities	2.22	10.16	9.93	5.49	4.29
Total Current Liabilities	4.08	14.69	14.79	11.49	7.33
Long-Term Debt	28.4	48.91	4.89	1.81	143.67
Other Long-Term Liabilities	15.62	18.32	18.26	247.76	12.11
Total Long-Term Liabilities	44.03	67.23	23.15	249.57	155.78
Total Liabilities	48.11	67.23	23.15	261.06	163.1
Total Debt	30.13	52.34	6.02	1.81	143.15
Debt Growth	-42.44%	770.14%	232.69%	-98.74%	-
Common Stock	0	0.05	0.05	0.01	0.01
Retained Earnings	-350.4	-275.64	-161	-102.84	-63.49
Comprehensive Income	0	0	-225.37	-233.05	-143.15
Shareholders' Equity	22.89	95.71	202.22	-95.72	-59.54
Total Liabilities and Equity	71	162.94	225.37	165.34	103.57
Net Cash / Debt	-5	18.7	127.47	97.9	-100.96
Net Cash / Debt Growth	-	-85.33%	30.20%	-	-
Net Cash Per Share	-3.12	11.76	80.48	60.85	-62.75
Working Capital	21.76	56.35	118.69	94.68	41.3
Book Value Per Share	14.26	60.21	127.69	-59.49	-37.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.